BioInvent International AB
STO:BINV
BioInvent International AB
Free Cash Flow
BioInvent International AB
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioInvent International AB
STO:BINV
|
Free Cash Flow
-kr390.6m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-18%
|
|
|
Biogaia AB
STO:BIOG B
|
Free Cash Flow
kr359.1m
|
CAGR 3-Years
19%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Free Cash Flow
kr59.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Free Cash Flow
kr655m
|
CAGR 3-Years
27%
|
CAGR 5-Years
15%
|
CAGR 10-Years
16%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Free Cash Flow
kr4.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
56%
|
|
|
BioArctic AB
STO:BIOA B
|
Free Cash Flow
-kr316.3m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BioInvent International AB
Glance View
BioInvent International AB engages in the research and development of novel and immuno-modulatory antibodies for the treatment of cancer. The company is headquartered in Lund, Skane and currently employs 84 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.
See Also
What is BioInvent International AB's Free Cash Flow?
Free Cash Flow
-390.6m
SEK
Based on the financial report for Dec 31, 2024, BioInvent International AB's Free Cash Flow amounts to -390.6m SEK.
What is BioInvent International AB's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-18%
Over the last year, the Free Cash Flow growth was -11%. The average annual Free Cash Flow growth rates for BioInvent International AB have been -15% over the past three years , -25% over the past five years , and -18% over the past ten years .
You don't have any saved screeners yet